A Conceptual Model of Food Cue Reactivity - PMC - PubMed Central, accessed April 22, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 22, 2025, GLP-1 and the Neurobiology of Eating Control: Recent Advances - Oxford Academic, accessed April 22, 2025, pmc.ncbi.nlm.nih.gov, accessed April 22, 2025, Taking a GLP-1
Sudden discontinuation does not cause dangerous withdrawal symptoms but results in loss of glycaemic control, return of appetite, and potential weight regain
GLP-1 receptor agonists (GLP-1 RAs) have demonstrated significant reductions in major adverse cardiovascular events and cardiometabolic benefits, prompting investigations into their role in HFpEF management
However, some people should not take BCAA supplements, including people who are pregnant or nursing, or people with maple syrup urine disease, a condition in which the body cannot break down BCAAs